Osiris Therapeutics, Inc.

CIK 1360886 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Osiris Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Apr 29, 201915-12B0001104659-19-024528
Apr 17, 2019S-8 POS0001104659-19-021846
Apr 17, 2019S-8 POS0001104659-19-021841
Apr 17, 201925-NSE0001354457-19-000209
Apr 17, 2019SC TO-T/A0001047469-19-002290
Apr 17, 201940001104659-19-021850
Apr 17, 201940001104659-19-021852
Apr 17, 201940001104659-19-021851
Apr 17, 2019S-8 POS0001104659-19-021842
Apr 17, 20198-K0001104659-19-021839
Apr 17, 2019S-8 POS0001104659-19-021844
Apr 17, 2019SC 14D9/A0001104659-19-021765
Apr 17, 2019S-8 POS0001104659-19-021845
Apr 16, 2019SC 14D9/A0001104659-19-021494
Apr 12, 2019SC TO-T/A0001047469-19-002185
Apr 10, 2019SC 14D9/A0001104659-19-020577
Apr 10, 2019SC TO-T/A0001047469-19-002106
Mar 27, 2019SC TO-T/A0001047469-19-001692
Mar 27, 2019SC 14D9/A0001104659-19-017865
Mar 20, 2019SC TO-T0001047469-19-001439
Mar 20, 2019SC 14D90001047469-19-001440
Mar 15, 201910-K0001558370-19-002094
Mar 12, 2019SC14D9C0001104659-19-014172
Mar 12, 2019SC14D9C0001104659-19-014294
Mar 12, 20198-K0001104659-19-014171